Global ENT Powered Instrument Market Size, Share, & COVID-19 Impact Analysis 2023-2029 - MedCore - Includes: Capital Equipment and Disposables

The global market for ENT powered instruments was valued at $881.6 million in 2022 and is anticipated to grow at a CAGR of 3.3% during the forecast period to reach $1.1 billion. The complete report suite on the global market for ENT powered instruments includes an analysis of the capital equipment and disposable markets.

MARKET DATA INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2029, and Historical Data to 2019
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL ENT POWERED INSTRUMENT MARKET INSIGHTS

The rise in otolaryngologic procedures worldwide is one of the primary factors driving the ENT powered instrument market. With increasing access to affordable healthcare and advanced technologies, more people are able to undergo ENT procedures, leading to an upsurge in demand for powered instruments. Additionally, the growth of healthcare services in developing economies is expected to further propel market growth.

GLOBAL ENT POWERED INSTRUMENT MARKET SHARE INSIGHTS

The Global ENT powered instrument market was led by Medtronic, Stryker, and Olympus.

Medtronic was the market leader in the ENT powered instrument market, with a dominant position in the power shaver segment, holding a majority share. The company's success is largely attributed to its two most popular products, the Straightshot® M4 and M5 Microdebriders, for which it coined the term "microdebrider". Medtronic also holds a leading position in the power drill market, with its portfolio of otologic drills, including Indigo, Visao®, and Midas Rex®.

MARKET SEGMENTATION SUMMARY

ENT Powered Instrument Market - MedCore - Includes:

• Subsegments of capital equipment and disposable markets.

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022
• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.